1. Home
  2. EXEL vs LBGJ Comparison

EXEL vs LBGJ Comparison

Compare EXEL & LBGJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • LBGJ
  • Stock Information
  • Founded
  • EXEL 1994
  • LBGJ 2007
  • Country
  • EXEL United States
  • LBGJ China
  • Employees
  • EXEL N/A
  • LBGJ 141
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • LBGJ
  • Sector
  • EXEL Health Care
  • LBGJ
  • Exchange
  • EXEL Nasdaq
  • LBGJ NYSE
  • Market Cap
  • EXEL 9.8B
  • LBGJ 24.7M
  • IPO Year
  • EXEL 2000
  • LBGJ 2024
  • Fundamental
  • Price
  • EXEL $38.55
  • LBGJ $1.32
  • Analyst Decision
  • EXEL Buy
  • LBGJ
  • Analyst Count
  • EXEL 18
  • LBGJ 0
  • Target Price
  • EXEL $37.59
  • LBGJ N/A
  • AVG Volume (30 Days)
  • EXEL 2.4M
  • LBGJ 25.6K
  • Earning Date
  • EXEL 05-09-2025
  • LBGJ 05-15-2025
  • Dividend Yield
  • EXEL N/A
  • LBGJ N/A
  • EPS Growth
  • EXEL 170.77
  • LBGJ N/A
  • EPS
  • EXEL 1.76
  • LBGJ N/A
  • Revenue
  • EXEL $2,168,701,000.00
  • LBGJ $10,794,015.00
  • Revenue This Year
  • EXEL $5.78
  • LBGJ N/A
  • Revenue Next Year
  • EXEL $10.94
  • LBGJ N/A
  • P/E Ratio
  • EXEL $21.91
  • LBGJ N/A
  • Revenue Growth
  • EXEL 18.50
  • LBGJ N/A
  • 52 Week Low
  • EXEL $20.14
  • LBGJ $1.02
  • 52 Week High
  • EXEL $40.02
  • LBGJ $5.50
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 63.64
  • LBGJ N/A
  • Support Level
  • EXEL $35.34
  • LBGJ N/A
  • Resistance Level
  • EXEL $37.67
  • LBGJ N/A
  • Average True Range (ATR)
  • EXEL 1.17
  • LBGJ 0.00
  • MACD
  • EXEL 0.34
  • LBGJ 0.00
  • Stochastic Oscillator
  • EXEL 96.71
  • LBGJ 0.00

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About LBGJ LI BANG INTERNATIONAL CORPORATION I

Li Bang International Corp Inc is a holding company. The firm through its subsidiaries engages in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China under its own Libang brand. In addition, its subsidiaries provide customers with comprehensive services, from commercial kitchen design in the early stage to equipment installation and after-sales maintenance.

Share on Social Networks: